Aberrant activated β-catenin signaling in colon cancer enhanced glycolysis; meanwhile, an NR4A1-β-catenin feed-forward loop happening in colon cancer cells proves from the side that NR4A1 may be involved in promoting glycolysis. Here, NR4A1 is linked to malignant colon neoplasm.